News
A new microchip invented by Scripps Research scientists can reveal how a person's antibodies interact with viruses—using just ...
Some antibodies neutralize the virus effectively, while others bind only weakly. Pinpointing exactly which parts of a virus ...
An antinuclear antibody test can help your doctor diagnose an autoimmune disease such as lupus. Find out how this blood test is done and what your results might mean.
A nasal ‘molecular shield’ developed by researchers may soon block mugwort pollen, offering relief from one of the most ...
Subcutaneous administration of the monoclonal antibody L9LS protected adults against controlled Plasmodium falciparum infection in a phase 1 trial. Whether a monoclonal antibody administered subcut ...
China-based biotech Biocytogen has signed a global licensing agreement with oncology-focused BeOne Medicines (SHA: 688235), ...
British techbio innovator Etcembly has signed a collaboration agreement with DJS Antibodies, a part of AbbVie, to accelerate the discovery of novel antibody therapeutics. Etcembly’s flagship AI ...
N6LS, a broadly neutralising antibody from ViiV Healthcare, could potentially be a partner for cabotegravir (Vocabria) in a long-acting HIV treatment regimen, according to results from the EMBRACE ...
A team of Ohio State researchers engineered a new antibody that could revolutionize influenza prevention through a nasal spray.
Versant Ventures has enlisted AbCellera as its antibody discovery house band. Off the back of its key role in the development of Eli Lilly’s COVID-19 antibody, AbCellera is set to provide ...
RQ Biotechnology Ltd. (RQ Bio) has announced that the first of its discovered monoclonal antibodies to prevent COVID-19 in vulnerable patients, AZD-3152, has entered clinical trials.
Etcembly has signed a collaboration agreement with DJS Antibodies, a part of AbbVie, to accelerate the discovery of novel antibody therapeutics.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results